{"id":19761,"date":"2018-08-14T08:15:27","date_gmt":"2018-08-14T11:15:27","guid":{"rendered":"https:\/\/infobioquimica.com\/new\/?p=19761"},"modified":"2019-06-03T13:57:36","modified_gmt":"2019-06-03T16:57:36","slug":"27-simposio-de-la-aacc-sobre-el-rol-de-point-of-care-testing","status":"publish","type":"post","link":"https:\/\/infobioquimica.com\/new\/2018\/08\/14\/27-simposio-de-la-aacc-sobre-el-rol-de-point-of-care-testing\/","title":{"rendered":"27\u00b0 Simposio de la AACC sobre el Rol de Point of Care Testing"},"content":{"rendered":"<p>Este evento se presenta en colaboraci\u00f3n con la Divisi\u00f3n de Pruebas Criticas y Punto de Cuidado de la AACC y la Federaci\u00f3n Internacional de Qu\u00edmica Cl\u00ednica y Medicina de Laboratorio (IFCC).<\/p>\n<p>El <strong>27 \u00b0 Simposio Internacional de C-PoCT<\/strong>, que se centrar\u00e1 en el papel actual y futuro de las pruebas en el punto de atenci\u00f3n en un entorno de atenci\u00f3n m\u00e9dica con \u00e9nfasis en el valor y la calidad de la atenci\u00f3n.<\/p>\n<p>Aprender\u00e1 c\u00f3mo las pruebas en el punto de atenci\u00f3n contribuyen al valor de la atenci\u00f3n m\u00e9dica a trav\u00e9s de un tiempo de respuesta m\u00e1s r\u00e1pido, costos de prueba m\u00e1s bajos, una mejor vinculaci\u00f3n del paciente con la atenci\u00f3n y los resultados, y una mayor satisfacci\u00f3n para los pacientes y los proveedores de atenci\u00f3n m\u00e9dica.<\/p>\n<p>Los temas de la sesi\u00f3n abordar\u00e1n la salud p\u00fablica y la prevenci\u00f3n de enfermedades, diagn\u00f3stico y monitoreo de enfermedades para la autogesti\u00f3n de pacientes cr\u00edticamente enfermos, en el hogar, pruebas directas al consumidor y tecnolog\u00edas nuevas \/ emergentes<\/p>\n<p>La presentaci\u00f3n especial de la sesi\u00f3n del\u00a0<strong>Federation of Clinical Chemistry (IFCC) \u2013 WG GMECC<\/strong>\u00a0ser\u00e1 el 29 de septiembre de 2018, de\u00a011:20\u2013 12:45:<\/p>\n<p><em><strong>Monitoreo de glucosa en pacientes cr\u00edticos; qu\u00e9 debemos saber?<\/strong><\/em><\/p>\n<p><em><strong>Una visi\u00f3n general del documento de la IFCC: \u00ab\u00bfC\u00f3mo se deben evaluar los medidores de glucosa para la atenci\u00f3n cr\u00edtica?\u00bb &#8211; <a href=\"http:\/\/www.ifcc.org\/media\/477215\/ifcc_wg-gmecc_terms_1-2.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">haga clic aqu\u00ed<\/a> para acceder al informe completo.<\/strong><\/em><\/p>\n<p>Oradores:<\/p>\n<ul>\n<li><strong>Cynthia Bowman<\/strong>, MD; Baystate Health, Springfield, MA \u2013 US;<\/li>\n<li><strong>Sean Cunningham<\/strong>, PhD, EuSpLM; Dublin, Ireland.<\/li>\n<\/ul>\n<p>Programa<\/p>\n<p>Photos and Credentials of Speakers<\/p>\n<p>*Program is subject to change<\/p>\n<h4>Wednesday, September 26, 2018<\/h4>\n<ul>\n<li>5:30 \u2013 6:30 pm WELCOME RECEPTION<\/li>\n<\/ul>\n<h4>Thursday, September 27, 2018<\/h4>\n<ul>\n<li>8:30 \u2013 8:45 am OPENING REMARKS. Leslie Donato, PhD (Committee chair); Mayo Clinic, Rochester, MN<\/li>\n<li>8:45 \u2013 9:20 am KEYNOTE PRESENTATION. The Value of POCT in Patient Diagnosis and Improved Clinical Outcomes. Keynote Speaker: Danielle Freedman, MB BS; Luton &amp; Dunstable University Hospital, Luton, United Kingdom<\/li>\n<li>9:20 \u2013 9:30 am Q&amp;A with Dr. Freedman<\/li>\n<\/ul>\n<p><strong>SESSION 1:<\/strong> POCT IN PUBLIC HEALTH AND DISEASE PREVENTION. Moderator: Nichole Korpi-Steiner, PhD; University of North Carolina Hospitals<\/p>\n<ul>\n<li>9:30 \u2013 9:35 am Moderator introduction to session<\/li>\n<li>9:35 \u2013 10:05 am HIV testing and Linkage to Care<br \/>\nDebbie Mohammed, PhD, MS, MPH; William Paterson University, Wayne, NJ<\/li>\n<li>10:05 \u2013 10:10 am Q&amp;A with Dr. Mohammed<\/li>\n<li>10:10 \u2013 10:35 am BREAK \u2013 NETWORKING AND VISIT EXHIBITORS<\/li>\n<li>10:35 \u2013 11:05 am Efficacy of Child-Parent Familial Cholesterol Screening in Primary Care<br \/>\nAmy Peterson, MD; University of Wisconsin School of Medicine and Public Health<\/li>\n<li>11:05 \u2013 11:10 am Q&amp;A with Speaker<\/li>\n<li>11:10 \u2013 11:40 am Lead Screening: Effectiveness and Analytical Considerations<br \/>\nDouglas Stickle, PhD; Jefferson University Hospital, Philadelphia, PA<\/li>\n<li>11:40 \u2013 11:45 am Q&amp;A with Dr. Stickle<\/li>\n<li>11:45 \u2013 11:55 am Point of Care Creatinine to Assist Clinical Decision Making in Suspected Sepsis in the Community.<br \/>\nDimitris Poulikakos, MD; Salford Royal NHS Foundation Trust<\/li>\n<li>11:55 am \u2013 12:00 pm Q&amp;A with Dimitrios Poulikakos<\/li>\n<li>12:15 \u2013 1:45 pm LUNCH AND VISIT EXHIBITORS<\/li>\n<\/ul>\n<p><strong>SESSION 2:<\/strong> DISEASE DIAGNOSIS AND MONITORING FOR THE CRITICALLY ILL<br \/>\nModerator: Brad Karon, MD, PhD; Mayo Clinic, Rochester, MN<\/p>\n<ul>\n<li>1:45 \u2013 1:50 pm Moderator introduction to session<\/li>\n<li>1:50 \u2013 2:20 pm The Benefits and Challenges of Point of Care Testing for Respiratory Tract Infection.\u00a0Leslie Wolf, PhD; Louisville Metro Public Health and Wellness Laboratory, Louisville, KY<\/li>\n<li>2:20 \u2013 2:25 pm Q&amp;A with Dr. Wolf<\/li>\n<li>2:25 \u2013 2:55 pm Hemostasis Testing for Liver Transplant.\u00a0Antonio Leon-Justel, MD; University Hospital, Institute of Biomedicine of Seville, Spain<\/li>\n<li>2:55 \u2013 3:00 pm Q&amp;A with Dr. Leon-Justel<\/li>\n<li>3:00 \u2013 3:25 pm BREAK \u2013 NETWORKING AND VISIT EXHIBITORS<\/li>\n<li>3:25 \u2013 3:55 pm Update on biomarkers for acute kidney injury.\u00a0Chirag Parikh, MD, PhD; Johns Hopkins University Medical Institutions, Baltimore, MD<\/li>\n<li>3:55 \u2013 4:00 pm Q&amp;A with Dr. Parikh<\/li>\n<li>4:00 \u2013 4:10 pm Clinical Impact of an Autocorrecting Blood Glucose Monitoring System in the Severely Burned Adult Population: A Pre- and Post-Implementation Comparison Study.\u00a0Nam Tran, MS, MAS, PhD; University of California, Davis, Davis, CA<\/li>\n<li>4:10 \u2013 4:15 pm Q&amp;A with Dr. Tran<\/li>\n<li>4:15 \u2013 4:25 pm Implementation and Ongoing Support of POCT in the World\u2019s Only Stroke Ambulance for Rural Stroke Care.\u00a0Anna F\u00fcez\u00e9ry, PhD; Royal Alexandra Hospital, Edmonton, Alberta, Canada<\/li>\n<li>4:25 \u2013 4:30 pm Q&amp;A with Dr. F\u00fcez\u00e9ry<\/li>\n<li>4:30 \u2013 5:30 pm RECEPTION WITH POSTER VIEWING AND VISIT EXHIBITORS<\/li>\n<\/ul>\n<h4>Friday, September 28, 2018<\/h4>\n<p>8:30 \u2013 9:30 am CORPORATE SUPPORTER PRESENTATIONS (Industry Viewpoints)<\/p>\n<p><strong>SESSION 3:<\/strong> POCT IN AT-HOME PATIENT SELF-MANAGEMENT FOR ACUTE AND CHRONIC DISEASES. Moderator: Rob Nerenz, PhD; Dartmouth-Hitchcock Medical Center, Hanover, NH<\/p>\n<ul>\n<li>9:30 \u2013 9:35 am Moderator introduction to session<\/li>\n<li>9:35 \u2013 10:05 am Continuous Glucose Monitors &#8211; Improved Outcomes, Challenges for Laboratorians.\u00a0Timothy Bailey, MD; Advanced Metabolic Care and Research Institute, University of California, San Diego, CA<\/li>\n<li>10:05 \u2013 10:10 am Q&amp;A with Dr. Bailey<\/li>\n<li>10:10 \u2013 10:40 am TBD<br \/>\nSpeaker TBD<\/li>\n<li>10:35 \u2013 10:45 am Q&amp;A withTBD<\/li>\n<li>10:45 \u2013 11:10 am BREAK \u2013 NETWORKING AND VISIT EXHIBITORS<\/li>\n<li>11:10 \u2013 11:40 am Monitoring Creatinine Following Renal Transplant.\u00a0Celine van Lint, MSc; Leiden University Medical Center, Netherlands<\/li>\n<li>11:40 \u2013 11:45 am Q&amp;A with Dr. van Lint<\/li>\n<li>11:45 \u2013 1:30 pm LUNCH AND VISIT EXHIBITORS<\/li>\n<\/ul>\n<p><strong>SESSION 4:<\/strong> POCT AND DIRECT TO CONSUMER TESTING.\u00a0Moderator: T. Scott Isbell, PhD; St. Louis University School of Medicine, MO<\/p>\n<ul>\n<li>1:30 \u2013 1:35 pm Moderator introduction to session<\/li>\n<li>1:35 \u2013 1:55 pm Digital Health and the Engaged Patient.\u00a0David Grenache, PhD; TriCore Reference Laboratories, NM<\/li>\n<li>1:55 \u2013 2:15 pm Legal Perspectives on Direct to Consumer Testing. Timothy Allen, MD, JD; University of Mississippi, Jackson, MS<\/li>\n<li>2:15 \u2013 2:35 pm Ethical Perspectives on Direct to Consumer Testing.\u00a0Anita Ho, PhD, MPH; The University of British Columbia, Vancouver, Canada<\/li>\n<li>2:35 \u2013 3:05 pm Panel Discussion and Q&amp;A with Session 4 speakers<\/li>\n<li>3:05 \u2013 3:35 pm NETWORKING AND VISIT EXHIBITORS<\/li>\n<li>5:30 \u2013 7:30 pm AWARDS RECEPTION at the National Press Club<\/li>\n<\/ul>\n<h4>Saturday, September 29, 2018<\/h4>\n<p><strong>SESSION 5<\/strong>: NEW AND EMERGING POCT TECHNOLOGIES. Moderator: Brenda Suh-Lailam, PhD; Lurie Children\u2019s Hospital, Chicago, IL<\/p>\n<ul>\n<li>8:30 \u2013 8:35 am Moderator introduction to session<\/li>\n<li>8:35 \u2013 9:05 am Ambient Ionization Mass Spectrometry for Point-of-Care Diagnostics.\u00a0Graham Cooks, PhD; Purdue University, West Lafayette, IN<\/li>\n<li>9:05 \u2013 9:15 am Q&amp;A with Dr. Cooks<\/li>\n<li>9:15 \u2013 9:45 am Genetic Testing Made Possible with a Smartphone<br \/>\nSyed Hashsham, PhD; Michigan State University, Lansing, MI<\/li>\n<li>9:45 \u2013 9:55 am Q&amp;A with Dr. Hashsham<\/li>\n<li>9:55 \u2013 10:15 am BREAK &#8211; NETWORKING and VISIT EXHIBITORS<\/li>\n<li>10:15 \u2013 10:45 am Sweat Analysis using Microfluidics.\u00a0John Rogers, PhD; Northwestern University School of Engineering, Chicago, IL<\/li>\n<li>10:45 \u2013 10:55 am Q&amp;A with Dr. Rogers<\/li>\n<li>10:55 \u2013 11:05 am Reducing Hospital Length of Stay and Readmission Rates in Surgical Inpatients with Diabetes Mellitus Through Improved Glycaemic Control Using an Automated Glucose System.<br \/>\nIrene Kopp, NP\/CDE; Nepean Diabetes Service, Penrith NSW, Australia<\/li>\n<li>11:05 \u2013 11:10 am Q&amp;A with Irene Kopp<\/li>\n<li>11:10 \u2013 11:20 am CLOSING REMARKS. Leslie Donato, PhD (Committee chair); Mayo Clinic, Rochester, MN<\/li>\n<li>11:20 \u2013 12:45 SPECIAL PRESENTATION FROM THE INTERNATIONAL FEDERATION OF CLINICAL CHEMISTRY (IFCC) Glucose monitoring in critically ill patients; what do we need to know? An overview of the IFCC report: \u00abHow Should Glucose Meters be Evaluated for Critical Care?\u00bb Cynthia Bowman, MD; Baystate Health, Springfield, MA. Sean Cunningham, PhD, EuSpLM; Dublin, Ireland<\/li>\n<\/ul>\n<h4>Informes e inscripci\u00f3n<\/h4>\n<ul>\n<li><a href=\"https:\/\/www.aacc.org\/store\/conferences\/11700\/the-role-of-point-of-care-testing-in-a-value-based-healthcare-landscape---27th-aacc-international\" target=\"_blank\" rel=\"noopener noreferrer\">aacc.org\/the-role-of-point-of-care-testing-in-a-value-based-healthcare-landscape&#8212;27th-aacc-international<\/a><\/li>\n<\/ul>\n<table>\n<tbody>\n<tr>\n<td style=\"background-color: #fcd688; width: 80%; text-align: center;\"><strong>Infobioquimica.org no dispone m\u00e1s datos que los aqu\u00ed publicados.<\/strong><br \/>\n<strong>Por favor, si necesita m\u00e1s informaci\u00f3n env\u00ede una consulta directa a los organizadores del evento.<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Este evento se presenta en colaboraci\u00f3n con la Divisi\u00f3n de Pruebas Criticas y Punto de Cuidado de la AACC y la Federaci\u00f3n Internacional de Qu\u00edmica Cl\u00ednica y Medicina de Laboratorio (IFCC). El 27 \u00b0 Simposio Internacional de C-PoCT, que se centrar\u00e1 en el papel actual y futuro de las pruebas en el punto de atenci\u00f3n [&hellip;]<\/p>\n","protected":false},"author":2620,"featured_media":19795,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"twitterCardType":"summary_large_image","cardImageID":0,"cardImage":"","cardTitle":"","cardDesc":"","cardImageAlt":"","cardPlayer":"","cardPlayerWidth":0,"cardPlayerHeight":0,"cardPlayerStream":"","cardPlayerCodec":"","footnotes":""},"categories":[28,26],"tags":[1036,6647,36193,35827,36191,15968,5601,36189,35845,36195,36187,504,36185],"class_list":["post-19761","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-congresos-y-conferencias","category-noticias-bioquimicas","tag-aacc","tag-asociacion-americana-de-quimica-clinica-aacc","tag-brenda-suh-lailam-es","tag-cynthia-bowman","tag-danielle-freedman","tag-diabetes-mellitus","tag-federacion-internacional-de-quimica-clinica-y-medicina-de-laboratorio-ifcc","tag-irene-kopp","tag-leslie-donato","tag-nichole-korpi-steiner-es","tag-sean-cunningham","tag-simposio","tag-valor-de-la-atencion-medica"],"acf":[],"_links":{"self":[{"href":"https:\/\/infobioquimica.com\/new\/wp-json\/wp\/v2\/posts\/19761","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/infobioquimica.com\/new\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/infobioquimica.com\/new\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/infobioquimica.com\/new\/wp-json\/wp\/v2\/users\/2620"}],"replies":[{"embeddable":true,"href":"https:\/\/infobioquimica.com\/new\/wp-json\/wp\/v2\/comments?post=19761"}],"version-history":[{"count":4,"href":"https:\/\/infobioquimica.com\/new\/wp-json\/wp\/v2\/posts\/19761\/revisions"}],"predecessor-version":[{"id":21508,"href":"https:\/\/infobioquimica.com\/new\/wp-json\/wp\/v2\/posts\/19761\/revisions\/21508"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/infobioquimica.com\/new\/wp-json\/wp\/v2\/media\/19795"}],"wp:attachment":[{"href":"https:\/\/infobioquimica.com\/new\/wp-json\/wp\/v2\/media?parent=19761"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/infobioquimica.com\/new\/wp-json\/wp\/v2\/categories?post=19761"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/infobioquimica.com\/new\/wp-json\/wp\/v2\/tags?post=19761"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}